Noom vs Polly

Neither Noom nor Polly has an FDA warning letter on record. On compounded semaglutide injection, the standing prices are within $1 a month of each other: $179 at Noom and $179 at Polly.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Noom / Polly

Noom logo

Noom

5.8/10

Polly logo

Polly

8.4/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$179/moCompounded semaglutide injection
$179/moCompounded semaglutide injection
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked November 2026

Neither Noom nor Polly pays us. Links to them earn nothing. Scores: Noom 5.8, Polly 8.4. How we are paid

What the record shows

  1. 01

    Neither Noom nor Polly has an FDA warning letter on record.

  2. 02

    Polly names two pharmacies, all 503A. Noom names no compounding pharmacy in our record.

  3. 03

    On compounded semaglutide injection, the standing prices are within $1 a month of each other: $179 at Noom and $179 at Polly.

  4. 04

    Only Noom lists a price for brand-name tirzepatide pen. Only Polly lists a price for compounded tirzepatide injection.

  5. 05

    Polly lists all 50 states. Noom publishes no state list.

  6. 06

    Noom states you can cancel at any time; Polly does not state its cancellation terms.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Noom

Polly

Compounded semaglutide injection

$179/mo

$2,148 a year

$179/mo

$2,148 a year

Compounded tirzepatide injection
Not sold or not priced

$279/mo

$3,348 a year

Brand-name tirzepatide pen

$349/mo

$4,188 a year

Not sold or not priced
Price includes
Clinician visits, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Not stated
Minimum term
Not stated
Month to month, or a 3- or 6-month supply charged at checkout
Refunds
Refunds only before a prescription is written; renewal charges are not refunded
Full refund only before the medical intake is submitted; 3- and 6-month plans cannot be refunded once the first month has passed
Early-exit fee
Not stated
Yes

Read off each seller’s own pages. Noom: October 30, 2026. Polly: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Noom

5.8/10
  • Sells brand-name tirzepatide pen, which Polly does not price
  • States you can cancel at any time
  • Names no compounding pharmacy
  • Publishes no state list

The case for Polly

8.4/10
  • Sells compounded tirzepatide injection, which Noom does not price
  • Names its compounding pharmacy

Scores

Noom 5.8 · Polly 8.4 out of 10. Six weighted parts.

Value25%

0.9A
vs
B
5.8

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
10.0

Accessibility10%

5.0A
vs
B
10.0

Support10%

4.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Noom vs Polly: questions

Neither Noom nor Polly has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Polly names two pharmacies, all 503A. Noom names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Neither, by more than $1 a month. Noom charges $179 a month and Polly $179 a month.
Noom states you can cancel at any time; refunds: refunds only before a prescription is written; renewal charges are not refunded. Polly does not state its cancellation terms.
Neither Noom nor Polly pays us. Links to them earn nothing. Scores: Noom 5.8, Polly 8.4.

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks